Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Some supplements and hormones can increase hair loss by raising DHT levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

PSA can help diagnose high androgen levels in women.

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Both birth control pills improved hormone levels and skin conditions in women with hyperandrogenism, but the one with drospirenone was more effective.

Men with early balding often have hormone levels similar to women with polycystic ovary syndrome.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.